Biochemistry in diagnosis and management of abnormal early pregnancy

Current Opinion in Obstetrics and Gynecology

Volumn 16, Issue 4, 2004, Pages 339-344

  Elson, Janine ^a   Jurkovic, Davor ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Biochemical markers; Early pregnancy; Ectopic pregnancy; Miscarriage; Ultrasound

Indexed keywords

CHORIONIC GONADOTROPIN; HYDROXYPROGESTERONE; INHIBIN A; PROGESTERONE; SOMATOMEDIN; BIOLOGICAL MARKER; INHIBIN; SOMATOMEDIN BINDING PROTEIN 1;

BIOCHEMISTRY; ECTOPIC PREGNANCY; FIRST TRIMESTER PREGNANCY; HUMAN; PREGNANCY DISORDER; PRIORITY JOURNAL; REVIEW; SPONTANEOUS ABORTION; FEMALE; METABOLISM; PREGNANCY; PREGNANCY OUTCOME;

17-ALPHA-HYDROXYPROGESTERONE; ABORTION, SPONTANEOUS; BIOLOGICAL MARKERS; CHORIONIC GONADOTROPIN; FEMALE; HUMANS; INHIBINS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; PREGNANCY; PREGNANCY OUTCOME; PROGESTERONE;

EID: 16544394271     PISSN: 1040872X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.gco.0000136501.81614.05     Document Type: Review

References (46)

1. Midgley AR Jr, Pierce GB Jr. Immunohistochemical localization of human chorionic gonadotrophin. J Exp Med 1962; 115:289-301.
2. Pittaway D, Reish R, Colston Wentz A. Doubling times of human chorionic gonadotrophin increase in early viable intrauterine pregnancies. Am J Obstet Gynecol 1985; 159:299-302.
3. Bernaschek G, Rudelsdorfer R, Csaicish P. Vaginal sonography versus serum human chorionic gonadotrophin in early detection of pregnancy. Am J Obstet Gynecol 1988; 158:608-611.
4. Shepherd RW, Patton PE, Novy MJ, Burry KA. Serial β-hCG measurements in the early detection of ectopic pregnancy. Obstet Gynecol 1990; 75:417-420.
5. Cacciatore B, Stenman U-H, Ylostalo P. Diagnosis of ectopic pregnancy by vaginal ultrasonography in combination with a discriminatory serum hCG level of 1000 IU/I (IRP). Br J Obstet Gynecol 1990; 97:904-908.
6. Stovall TG, Ling FW, Carson SA, Buster JE. Nonsurgical diagnosis and treatment of tubal pregnancy. Fertil Steril 1990; 54:537-538.
7. Ankum WM, Van der Veen F, Hammerlunck JVTH, Lammes FB. Transvaginal sonography and human chorionic gonadotrophin measurements in suspected ectopic pregnancy: a detailed analysis of a diagnostic approach. Hum Reprod 1993; 8:1307-1311
8. Barnhart KT, Simhan H, Kamelle SA. Diagnostic accuracy of ultrasound above and below the beta-hCG discriminatory zone. Obstet Gynecol 1999; 94:583-587.
9. Lower AM, Yovich JL. The value of serum levels of oestrodiol, progesterone and β-human chorionic gonadotrophin in the prediction of early pregnancy loss. Hum Reprod 1992; 7:711-717.
10. Zegers-Hochschild F, Altieri E, Fabres C, et al. Predictive value of human chorionic gonadotrophin in the outcome of early pregnancy after in-vitro fertilization and spontaneous conception. Hum Reprod 1994; 9:1550-1555.
11. Korhonen J, Stenman U-H, Ylostalo P. Serum human chorionic gonadotrophin dynamics during spontaneous resolution of ectopic pregnancy. Fertil Steril 1994; 61:632-636.
12. Elson J, Tailor A, Banerjee S, et al. Expectant management of tubal ectopic pregnancy: prediction of successful outcome using decision tree analysis. Ultrasound Obstet Gynecol 2004; 23:552-556. This study demonstrates a novel use of decision tree analysis for prediction of expectant management of tubal ectopic pregnancies.
13. Sowter MC, Farquhar CM, Petrie KJ, Gudex G. A randomised trial comparing single dose systemic methotrexate and laparoscopic surgery for the treatment of unruptured tubal ectopic pregnancy. Br J Obstet Gynecol 2001; 108:192-203.
14. Abraham GE, Odell WD, Swerdloff RS, et al. Simultaneous radioimmunoassay of plasma FSH, LH, progesterone 17-hydroxyprogesterone, and estradiol-17b during the menstrual cycle. J Clin Endocrinol Metab 1972; 34:312-318.
15. Lindbert BS, Johansson EDB, Nilsson BA. Plasma levels of non-conjugated oestrone, oestradiol-17b and oestriol during uncomplicated pregnancy. Acta Obstet Gynecol Scand 1974; 32:21-36.
16. Tulchinsky D, Hobel CJ, Yeager E, Marshall JR. Plasma estrone, estradiol, estriol, progesterone, and 17-hydroxyprogesterone in human pregnancy. I: Normal pregnancy. Am J Obstet Gynecol 1972; 112:1095-1100.
17. Siiteri PK, Febres F, Clemens LE, et al. Progesterone and maintenance of pregnancy: is progesterone nature's immunosuppressant? Ann N Y Acad Sci 1977; 286:384-397.
18. Hahlin M, Sjoblom P, Lindblom B. Combined use of progesterone and human chorionic gonadotrophin determinations for differential diagnosis of very early pregnancy. Fertil Steril 1991; 55:492-496.
19. Choe JK, Check JH, Nowroozi K, et al. Serum progesterone and 17-hydroxyprogesterone in the diagnosis of ectopic pregnancies and the value of progesterone replacement in intrauterine pregnancies when serum progesterone levels are low. Gynecol Obstet Invest 1992; 34:133-138.
20. Stewart BK, Nazar-Stewart V, Toivola B. Biochemical discrimination of pathologic pregnancy from early, normal intrauterine gestation in symptomatic patients. Clin Chem 1995; 103:386-390.
21. Sauer M, Gorrill MJ, Rodi IA, et al. Corpus luteum activity in tubal pregnancy. Obstet Gynecol 1988; 71:667-670.
22. Hahlin M, Thorburn J, Bryman I. The expectant management of early pregnancies of unknown site. Hum Reprod 1995; 10:1223-1227.
23. Banerjee S, Aslam N, Zosmer N, et al. The expectant management of women with early pregnancies of unknown location. Ultrasound Obstet Gynecol 1999; 16:231-236.
24. Banerjee S, Aslam N, Woelfer B, et al. Expectant management of early pregnancies of unknown location: a prospective evaluation of methods to predict spontaneous resolution of pregnancy. Br J Obstet Gynecol 2001; 108:158-163.
25. Cunningham DS, Brodnik RM, Rayl DL, et al. Suboptimal progesterone production in pathologic pregnancies. J Rep Med 1993; 38:301-303.
26. Aksoy S, Celikkanat H, Senoz S, Gokmen O. The prognostic value of serum estrodiol, progesterone, testosterone and free testosterone levels in detecting early abortions. Eur J Obstet Gynecol Reprod Biol 1996; 67:5-8.
27. Riss PA, Radivojevic K, Bieglemeyer C. Serum progesterone and human chorionic gonadotrophin in very early pregnancy: implications for clinical management. Eur J Obstet Gynecol Reprod Biol 1989; 32:71-77.
28. Elson J, Salim R, Tailor A, et al. Prediction of early pregnancy viability in the absence of an ultrasonically detectable embryo. Ultrasound Obstet Gynecol 2003; 21:57-61. The development of a unique logistic regression model combining serum progesterone with ultrasound to predict pregnancy viability.
29. Ransom MX, Garcia AJ, Bohrer M, et al. Serum progesterone as a predictor of methotrexate success in the treatment of ectopic pregnancy. Obstet Gynecol 1994; 83:1033-1037.
30. Tulchinsky D, Hobel CJ. Plasma human chorionic gonadotrophin, estrone, estradiol, estriol, progesterone and 17 α-hydroxyprogesterone in human pregnancy. III: Early normal pregnancy. Am J Obstet Gynecol 1973; 117:884-893.
31. Check JH, Vaze MM, Epstein R, Wu CH, et al. 17-Hydroxyprogesterone level as a marker for corpus luteum function in aborters versus nonaborters. Int J Fertil 1990; 35:112-115.
32. Muttukrishna S, Fowler PA, Groome NP, et al. Serum concentrations of dimeric inhibin during spontaneous menstrual cycle and after treatment with endogenous gonadotrophin. Hum Reprod 1994; 9:1634-1642.
33. Santoro N, Schneyer AL, Ibrahim J, Scmidt CL. Gonadotrophin and inhibin concentrations in early pregnancy in women with or without corporea lutea. Obstet Gynecol 1992; 79:579-585.
34. Lockwood GM, Ledger WL, Barlow DH, et al. Measurement of inhibin and activin in early human pregnancy: demonstration of fetoplacental origin and role in prediction of early-pregnancy outcome. Biol Reprod 1997; 57:1490-1494.
35. Illingworth PJ, Groome NP, Duncan WC, et al. Measurement of circulating inhibin forms during establishment of pregnancy. J Clin Endocrinol Metab 1996; 81:1471-1475.
36. Muttukrishna S, Child TJ, Groome NP, Ledger WL. Fetoplacental unit is the major source of inhibin A and activin A in early pregnancy. Hum Reprod 1997; 12:1089-1093.
37. Webley GE, Marsden PL, Knight PG. Differential control of immunoreactive alpha-inhibin and progesterone production by marmoset luteal cells in vitro: evidence for a paracrine action of alpha-inhibin on basal and gonadotrophin-stimulated progesterone production. Biol Reprod 1994; 50:1394-1402.
38. Glennon Phipps M, Hogan JW, Peipert JF, et al. Progesterone, inhibin, and hCG multiple marker strategy to differentiate viable from nonviable pregnancies. Obstet Gynecol 2000; 95:227-231.
39. Muttukrishna S, Jauniaux E, Greenwold N, et al. Circulating levels of inhibin A, activin A and follistatin in missed and recurrent miscarriages. Hum Reprod 2002; 17:3072-3078.
40. Lahiri S, Anobile CJ, Stewart P, Ledger W. Changes in circulating concentrations of inhibins A and pro α-C during first trimester medical termination of pregnancy. Hum Reprod 2003; 18:744-748. This paper outlines the interactions of the inhibins in early pregnancy and examines their possible role in failing pregnancies.
41. Shimasaki S, Ling N. Identification and molecular characterisation of insulin-like growth factor binding proteins (IGFBP-1, -2, -3, -4, -5, -6). Prog Growth Factor Res 1992; 3:243-266.
42. Rutanen E-M. Insulin-like growth factor binding protein-1. Sem Reprod Endocrinol 1992; 10:154-162.
43. Drop SL, Kortleve DJ, Guyda HJ, et al. Immunoassay of a somatomedin-binding protein from human amniotic fluid: levels in fetal, neonatal and adult sera. J Clin Endocrinol Metab 1984; 59:908-915.
44. 1 integrin and inhibits cytotrophoblast invasion into decidualized endometrial stromal cultures. GH & IGF Res 1998; 8:21-31.
45. Nielsen S, Hahlin M, Oden A. Using a logistic regression model to identify women with first-trimester spontaneous abortion suitable for expectant management. Br J Obstet Gynecol 1996; 103:1230-1235.
46. Elson J, Salim R, Lawrence A, et al. The value of serum biochemistry in the expectant management of incomplete miscarriage. Ultrasound Obstet Gynecol 2003; 22 (Suppl 1):53.